Moreover, we showed for the first time that the sulfonated form of DHEA, DHEA-S, can reduce IL-8 and TNF-α levels in PBC-like cholangiocytes (H69-miR506) and the IL-13 level in hepatocytes (Hep-G2). Here, IL13 is linked to primary biliary cholangitis.